Expects Double-Digit Adjusted EBITDA Growth in 2025* SAN DIEGO, March 26, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced ...

Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025. Regulatory path for VAR 200's ...

Don't miss out on the headlines from AFL. Followed categories will be added to My News.